Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
Portfolio Pulse from Happy Mohamed
Agile Therapeutics, Inc. (NASDAQ:AGRX) has announced partnerships with FPA Women's Health and vitaCare Prescription Services to expand access to its low-dose weekly birth control patch, Twirla. The partnerships will help Agile reach its target net revenue of $25-$30 million for the year. Telehealth platforms like Nurx, which Agile has also partnered with, provide birth control prescriptions and other basic healthcare services to patients nationwide, filling gaps in America's contraception landscape.
July 18, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Agile Therapeutics' partnerships with FPA Women's Health, vitaCare Prescription Services, and Nurx are expected to expand access to its birth control patch, Twirla, and help the company reach its target net revenue of $25-$30 million.
The partnerships with FPA Women's Health, vitaCare Prescription Services, and Nurx will expand the availability of Agile's birth control patch, Twirla. This increased accessibility is likely to boost sales, helping Agile reach its target net revenue for the year. Therefore, the news is expected to have a positive impact on Agile's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100